Pouliot, F., Lodde, M., Besançon, M., Castonguay, V., Morin-Coulombe, A., Fradet, V., … Beauregard, J.-M. (2026). Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian center. Canadian Urological Association Journal, 20(6). https://doi.org/10.5489/cuaj.9398